Login / Signup

Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection.

Yen-Chun LiuWen-Juei JengRong-Nan Chien
Published in: Alimentary pharmacology & therapeutics (2023)
Keyphrases
  • hepatitis b virus
  • stem cells
  • replacement therapy